Cluster composition

Functions

CategoryNameIntersectionWithQueryPValueGenesInTermGenesInQueryGenesInTermInQueryID
GeneOntologyMolecularFunctionubiquitin-like ligase-substrate adaptor activity

PRAMEF7 PRAMEF33 PRAMEF10 AMBRA1 PRAMEF17 PRAMEF8

3.18e-05821476GO:1990756
GeneOntologyMolecularFunctionnuclear retinoic acid receptor binding

PRAMEF7 PRAMEF33 PRAMEF10 PRAMEF17 PRAMEF8

5.22e-05551475GO:0042974
GeneOntologyMolecularFunctionenzyme-substrate adaptor activity

PRAMEF7 PRAMEF33 PRAMEF10 AMBRA1 PRAMEF17 PRAMEF8

7.29e-05951476GO:0140767
GeneOntologyMolecularFunctioncytoskeletal motor activity

MYO7B DYNC2H1 DNAH1 DNAI1 MYO15A DNAH5

2.41e-041181476GO:0003774
GeneOntologyMolecularFunctionminus-end-directed microtubule motor activity

DYNC2H1 DNAH1 DNAH5

2.94e-04181473GO:0008569
GeneOntologyCellularComponentCul2-RING ubiquitin ligase complex

PRAMEF7 PRAMEF33 PRAMEF10 ZSWIM5 PRAMEF17 PRAMEF8

9.24e-07471476GO:0031462
GeneOntologyCellularComponentmotile cilium

CUL3 PRAMEF7 PRAMEF10 DYNC2H1 PRAMEF17 PRAMEF8 DNAH1 DNAI1 CFAP52 SLC22A14 DNAH5 MORN5

8.22e-0635514712GO:0031514
GeneOntologyCellularComponentcullin-RING ubiquitin ligase complex

CUL3 PRAMEF7 PRAMEF33 PRAMEF10 ZSWIM5 AMBRA1 PRAMEF17 PRAMEF8 UBE2S

1.97e-052121479GO:0031461
GeneOntologyCellularComponentubiquitin ligase complex

CUL3 PRAMEF7 PRAMEF33 PRAMEF10 ZSWIM5 AMBRA1 PRAMEF17 PRAMEF8 NEDD4 FBXO8 UBE2S

4.06e-0535214711GO:0000151
GeneOntologyCellularComponentcilium

CUL3 PRAMEF7 CACNA1F PRAMEF10 DYNC2H1 AMBRA1 PRAMEF17 PRAMEF8 TTLL7 DNAH1 DNAI1 CFAP52 GUCY2F SLC22A14 DNAH5 USH2A MORN5

1.98e-0489814717GO:0005929
GeneOntologyCellularComponentsecretory granule

PRAMEF7 PRAMEF10 ACLY PENK GAS6 FNDC3A PRAMEF17 CHI3L1 PRAMEF8 KLK3 SPX ANGPTL6 AGA SURF4 SERPINF2 CTSD RHOF NCKAP1L

2.79e-04101414718GO:0030141
GeneOntologyCellularComponent9+2 motile cilium

CUL3 DYNC2H1 DNAH1 DNAI1 CFAP52 SLC22A14 DNAH5 MORN5

2.88e-042381478GO:0097729
GeneOntologyCellularComponentsecretory vesicle

PRAMEF7 PRAMEF10 ACLY SGTA PENK GAS6 SLC5A7 FNDC3A PRAMEF17 CHI3L1 PRAMEF8 KLK3 SPX ANGPTL6 AGA SURF4 SERPINF2 CTSD RHOF NCKAP1L

4.65e-04124614720GO:0099503
GeneOntologyCellularComponentdynein complex

DYNC2H1 DNAH1 DNAI1 DNAH5

5.65e-04541474GO:0030286
GeneOntologyCellularComponentaxonemal dynein complex

DNAH1 DNAI1 DNAH5

7.00e-04251473GO:0005858
GeneOntologyCellularComponentactin-based cell projection

VIL1 MYO7B FSCN3 SLC34A2 PKHD1L1 NEDD4 MYO15A USH2A

8.02e-042781478GO:0098858
MousePhenoabnormal spermatogonia proliferation

PRAMEF7 PRAMEF33 PRAMEF10 PRAMEF17 PRAMEF8 CIT

3.44e-06471246MP:0002685
DomainPRAME_family

PRAMEF7 PRAMEF10 PRAMEF17 PRAMEF8

1.27e-05191464IPR026271
DomainNck-associated_protein-1

NCKAP1 NCKAP1L

6.07e-0521462IPR019137
DomainNckap1

NCKAP1 NCKAP1L

6.07e-0521462PF09735
DomainDynein_heavy_chain_D4_dom

DYNC2H1 DNAH1 DNAH5

1.60e-04141463IPR024317
DomainDynein_HC_stalk

DYNC2H1 DNAH1 DNAH5

1.60e-04141463IPR024743
DomainDynein_heavy_dom-2

DYNC2H1 DNAH1 DNAH5

1.60e-04141463IPR013602
DomainDHC_N2

DYNC2H1 DNAH1 DNAH5

1.60e-04141463PF08393
DomainATPase_dyneun-rel_AAA

DYNC2H1 DNAH1 DNAH5

1.60e-04141463IPR011704
DomainMT

DYNC2H1 DNAH1 DNAH5

1.60e-04141463PF12777
DomainAAA_8

DYNC2H1 DNAH1 DNAH5

1.60e-04141463PF12780
DomainAAA_5

DYNC2H1 DNAH1 DNAH5

1.60e-04141463PF07728
DomainDHC_fam

DYNC2H1 DNAH1 DNAH5

1.99e-04151463IPR026983
DomainDynein_heavy

DYNC2H1 DNAH1 DNAH5

1.99e-04151463PF03028
DomainDynein_heavy_dom

DYNC2H1 DNAH1 DNAH5

1.99e-04151463IPR004273
Pubmed

Preferentially Expressed Antigen in Melanoma (PRAME) and the PRAME Family of Leucine-Rich Repeat Proteins.

PRAMEF7 PRAMEF33 PRAMEF10 PRAMEF17 PRAMEF8

1.99e-0820149526694250
Pubmed

Sertoli cell-only phenotype and scRNA-seq define PRAMEF12 as a factor essential for spermatogenesis in mice.

PRAMEF7 PRAMEF33 PRAMEF10 PRAMEF17 PRAMEF8

3.35e-0822149531729367
Pubmed

MAGE-B4, a binding partner of PRAMEF12, is dispensable for spermatogenesis and male fertility in mice.

PRAMEF7 PRAMEF33 PRAMEF10 PRAMEF17 PRAMEF8

6.69e-0825149537451217
Pubmed

Differences in gene expression between mouse and human for dynamically regulated genes in early embryo.

PRAMEF7 PRAMEF33 PRAMEF10 PRAMEF17 PRAMEF8

1.22e-0728149525089626
Pubmed

Thirteen Ovary-Enriched Genes Are Individually Not Essential for Female Fertility in Mice.

PRAMEF7 PRAMEF33 PRAMEF10 PRAMEF17 PRAMEF8

1.76e-0730149538786026
Pubmed

Mutations in dynein genes in patients affected by isolated non-syndromic asthenozoospermia.

DNAH1 DNAI1 DNAH5

3.07e-074149318492703
Pubmed

Retinoic acid receptors are required for skeletal growth, matrix homeostasis and growth plate function in postnatal mouse.

PRAMEF7 PRAMEF33 PRAMEF10 PRAMEF17 PRAMEF8

3.95e-0735149519389355
Pubmed

Differential expression of PRAMEL1, a cancer/testis antigen, during spermatogenesis in the mouse.

PRAMEF7 PRAMEF10 PRAMEF17 PRAMEF8

7.37e-0717149423565261
Pubmed

Mouse Pramel1 regulates spermatogonial development by inhibiting retinoic acid signaling during spermatogenesis.

PRAMEF7 PRAMEF10 PRAMEF17 PRAMEF8

7.37e-0717149437781892
Pubmed

The promoter of the oocyte-specific gene, Oog1, functions in both male and female meiotic germ cells in transgenic mice.

PRAMEF7 PRAMEF10 PRAMEF17 PRAMEF8

9.45e-0718149423894331
Pubmed

Pramel15 facilitates zygotic nuclear DNMT1 degradation and DNA demethylation.

PRAMEF7 PRAMEF10 PRAMEF17 PRAMEF8

9.45e-0718149439181896
Pubmed

Oogenesin is a novel mouse protein expressed in oocytes and early cleavage-stage embryos.

PRAMEF7 PRAMEF10 PRAMEF17 PRAMEF8

9.45e-0718149412890732
Pubmed

Oocyte-specific gene Oog1 suppresses the expression of spermatogenesis-specific genes in oocytes.

PRAMEF7 PRAMEF10 PRAMEF17 PRAMEF8

9.45e-0718149429731491
Pubmed

Identification of a new expanding family of genes characterized by atypical LRR domains. Localization of a cluster preferentially expressed in oocyte.

PRAMEF7 PRAMEF10 PRAMEF17 PRAMEF8

9.45e-0718149414675769
Pubmed

Pramel7 mediates ground-state pluripotency through proteasomal-epigenetic combined pathways.

PRAMEF7 PRAMEF10 PRAMEF17 PRAMEF8

1.19e-0619149428604677
Pubmed

Oog1, an oocyte-specific protein, interacts with Ras and Ras-signaling proteins during early embryogenesis.

PRAMEF7 PRAMEF10 PRAMEF17 PRAMEF8

1.49e-0620149416580637
Pubmed

Pramel7 mediates LIF/STAT3-dependent self-renewal in embryonic stem cells.

PRAMEF7 PRAMEF10 PRAMEF17 PRAMEF8

1.49e-0620149421425410
Pubmed

Mbd3, a component of the NuRD co-repressor complex, is required for development of pluripotent cells.

PRAMEF7 PRAMEF10 PRAMEF17 PRAMEF8 MBD3

1.61e-0646149517287250
Pubmed

DUX is a non-essential synchronizer of zygotic genome activation.

PRAMEF7 PRAMEF33 PRAMEF10 PRAMEF17 PRAMEF8

2.45e-0650149531806660
Pubmed

Oogenesis specific genes (Nobox, Oct4, Bmp15, Gdf9, Oogenesin1 and Oogenesin2) are differentially expressed during natural and gonadotropin-induced mouse follicular development.

PRAMEF7 PRAMEF10 PRAMEF17 PRAMEF8

2.69e-0623149419480014
Pubmed

LMBR1L regulates lymphopoiesis through Wnt/β-catenin signaling.

EMC1 NCKAP1 DYNC2H1 ACLY ESYT1 SGTA POLR2B SRM FNDC3A PLXNB2 CEBPZ SLC25A1 SURF4 ASNS PRKDC VCPIP1

3.15e-069421491631073040
Pubmed

Incomplete reactivation of Oct4-related genes in mouse embryos cloned from somatic nuclei.

PRAMEF7 PRAMEF10 PRAMEF17 PRAMEF8

3.82e-0625149412620990
Pubmed

Expression profiling in transgenic FVB/N embryonic stem cells overexpressing STAT3.

PRAMEF7 PRAMEF10 PRAMEF17 PRAMEF8

4.49e-0626149418500982
Pubmed

ZAR1 and ZAR2 are required for oocyte meiotic maturation by regulating the maternal transcriptome and mRNA translational activation.

PRAMEF7 PRAMEF10 PRAMEF17 PRAMEF8 TOP2A

5.15e-0658149531598710
Pubmed

A dual-activity topoisomerase complex regulates mRNA translation and turnover.

ABCC3 NRF1 KALRN NSD2 ESYT1 AMBRA1 PLXNB2 CIT MBD3 MFSD12 ENTPD2 MFN2 LRRC14 PRKDC CPVL RHOF BAHCC1

5.66e-0611051491735748872
Pubmed

Mapping the NPHP-JBTS-MKS protein network reveals ciliopathy disease genes and pathways.

PRAMEF7 PRAMEF10 ZSWIM5 ESYT1 POLR2B PRAMEF17 PRAMEF8 FOXA2 ANGPTL6 GUCY2C PRKDC MYO15A

6.24e-065641491221565611
Pubmed

Targeting the p300/NONO axis sensitizes melanoma cells to BRAF inhibitors.

AMBRA1 ARAF BRAF PRKDC

8.13e-0630149434017080
Pubmed

Defining human ERAD networks through an integrative mapping strategy.

EMC1 ESYT1 YIF1B SURF4 PRKDC USH2A CPVL

1.03e-05173149722119785
Pubmed

LSM14B is essential for oocyte meiotic maturation by regulating maternal mRNA storage and clearance.

PRAMEF7 PRAMEF10 PRAMEF17 PRAMEF8

1.06e-0532149437889087
Pubmed

Disease-associated KBTBD4 mutations in medulloblastoma elicit neomorphic ubiquitylation activity to promote CoREST degradation.

CUL3 P4HA2 POLR2B ARAF

1.71e-0536149435379950
Pubmed

CD100-Plexin-B2 Promotes the Inflammation in Psoriasis by Activating NF-κB and the Inflammasome in Keratinocytes.

SEMA4D PLXNB2

1.82e-052149228927892
Pubmed

hSGT interacts with the N-terminal region of myostatin.

SGTA MSTN

1.82e-052149214623262
Pubmed

Lower serum CA125 level, negative vascular invasion, and wild BRAF were strongly associated with better 2-year disease-free survival in patients with stage III colorectal cancer who received adjuvant chemotherapy.

MUC16 BRAF

1.82e-052149229562502
Pubmed

Congenital heart disease and other heterotaxic defects in a large cohort of patients with primary ciliary dyskinesia.

DNAI1 DNAH5

1.82e-052149217515466
Pubmed

The HEM proteins: a novel family of tissue-specific transmembrane proteins expressed from invertebrates through mammals with an essential function in oogenesis.

NCKAP1 NCKAP1L

1.82e-05214927643388
Pubmed

Primary ciliary dyskinesia: improving the diagnostic approach.

DNAI1 DNAH5

1.82e-052149219300264
Pubmed

Serum YKL-40 levels in patients with ovarian cancer and women with BRCA1 gene mutation--comparison to CA 125 antigen.

MUC16 CHI3L1

1.82e-052149220099501
Pubmed

Biochemical and Functional Characterization of RNF213 (Mysterin) R4810K, a Susceptibility Mutation of Moyamoya Disease, in Angiogenesis In Vitro and In Vivo.

RNF213 RNF123

1.82e-052149226126547
Pubmed

The CD100 receptor interacts with its plexin B2 ligand to regulate epidermal γδ T cell function.

SEMA4D PLXNB2

1.82e-052149222902232
Pubmed

Preoperative serum levels of YKL 40 and CA125 as a prognostic indicators in patients with endometrial cancer.

MUC16 CHI3L1

1.82e-052149228624692
Pubmed

Molecular and biochemical characterization of a novel oxysterol-binding protein (OSBP2) highly expressed in retina.

OSBP OSBP2

1.82e-052149211278871
Pubmed

Dysregulation of Rnf 213 gene contributes to T cell response via antigen uptake, processing, and presentation.

RNF213 RNF123

1.82e-052149233973242
Pubmed

New Insights into Behçet's Syndrome Metabolic Reprogramming: Citrate Pathway Dysregulation.

ACLY SLC25A1

1.82e-052149230050389
Pubmed

Acetylation of ELF5 suppresses breast cancer progression by promoting its degradation and targeting CCND1.

CUL3 PPAN EMC1 ACLY RRM1 IWS1 OSBP ASNS RBM7 UBE2S PRKDC LGR6

2.66e-056531491233742100
Pubmed

Identification of dynein heavy chain genes expressed in human and mouse testis: chromosomal localization of an axonemal dynein gene.

DYNC2H1 DNAH1 DNAH5

2.71e-051414939373155
Pubmed

Large-scale characterization of HeLa cell nuclear phosphoproteins.

CUL3 PPAN ACLY SGTA IWS1 OSBP BRAF RBM7 PRKDC RERE TOP2A ARHGEF6 VCPIP1

3.10e-057741491315302935
Pubmed

Epilepsy- and intellectual disability-associated CYFIP2 interacts with both actin regulators and RNA-binding proteins in the neonatal mouse forebrain.

NCKAP1 NSD2 NMRAL1 MBD3 MFN2 ELAVL3

3.68e-05143149632560809
Pubmed

Systematically defining selective autophagy receptor-specific cargo using autophagosome content profiling.

P4HA2 EMC1 NCKAP1 ACLY ESYT1 POLR2B SRM RRM1 PLXNB2 MBD3 MFSD12 TMEM160 SURF4 MFN2 UBE2S PRKDC CTSD

4.36e-0512971491733545068
Pubmed

Hepatitis B Virus HBx Protein Mediates the Degradation of Host Restriction Factors through the Cullin 4 DDB1 E3 Ubiquitin Ligase Complex.

NCKAP1 KALRN POLR2B HKDC1 RNF213 FNDC3A CTSD TNS3

5.33e-05304149832235678
Pubmed

Reduced expression of semaphorin 4D and plexin-B in breast cancer is associated with poorer prognosis and the potential linkage with oestrogen receptor.

SEMA4D PLXNB2

5.45e-053149226035216
Pubmed

RAF inhibitors prime wild-type RAF to activate the MAPK pathway and enhance growth.

ARAF BRAF

5.45e-053149220130576
Pubmed

Mutation analysis of the BRAF, ARAF and RAF-1 genes in human colorectal adenocarcinomas.

ARAF BRAF

5.45e-053149214688025
Pubmed

Expression of raf family proto-oncogenes in normal mouse tissues.

ARAF BRAF

5.45e-05314921690378
Pubmed

Endothelial apoptosis in Braf-deficient mice.

ARAF BRAF

5.45e-05314929207797
Pubmed

Effects of Raf dimerization and its inhibition on normal and disease-associated Raf signaling.

ARAF BRAF

5.45e-053149223352452
Pubmed

CD100 and plexins B2 and B1 mediate monocyte-endothelial cell adhesion and might take part in atherogenesis.

SEMA4D PLXNB2

5.45e-053149226275342
Pubmed

Gene network analysis of oxidative stress-mediated drug sensitivity in resistant ovarian carcinoma cells.

PRKDC ARHGEF6

5.45e-053149219918261
Pubmed

Plexin B2 and Semaphorin 4C Guide T Cell Recruitment and Function in the Germinal Center.

SEMA4D PLXNB2

5.45e-053149228467912
Pubmed

Overlapping and specific functions of Braf and Craf-1 proto-oncogenes during mouse embryogenesis.

ARAF BRAF

5.45e-053149210704835
Pubmed

PP2Cδ Controls the Differentiation and Function of Dendritic Cells Through Regulating the NSD2/mTORC2/ACLY Pathway.

NSD2 ACLY

5.45e-053149235069527
Pubmed

Identification of histological markers for malignant glioma by genome-wide expression analysis: dynein, alpha-PIX and sorcin.

DYNC2H1 ARHGEF6

5.45e-053149216320026
Pubmed

ARAF acts as a scaffold to stabilize BRAF:CRAF heterodimers.

ARAF BRAF

5.45e-053149222926515
Pubmed

Osteopontin is cleaved at multiple sites close to its integrin-binding motifs in milk and is a novel substrate for plasmin and cathepsin D.

SERPINF2 CTSD

5.45e-053149220071328
Pubmed

DNAH6 and Its Interactions with PCD Genes in Heterotaxy and Primary Ciliary Dyskinesia.

DNAI1 DNAH5

5.45e-053149226918822
Pubmed

The high-affinity choline transporter CHT1 is regulated by the ubiquitin ligase Nedd4-2.

SLC5A7 NEDD4

5.45e-053149222361880
Pubmed

Loss of Ambra1 promotes melanoma growth and invasion.

AMBRA1 BRAF

5.45e-053149233953176
Pubmed

Mislocalization of DNAH5 and DNAH9 in respiratory cells from patients with primary ciliary dyskinesia.

DNAI1 DNAH5

5.45e-053149215750039
Pubmed

Sema4D stimulates axonal outgrowth of embryonic DRG sensory neurones.

SEMA4D PLXNB2

5.45e-053149215330859
Pubmed

Upregulation of the Na⁺-coupled phosphate cotransporters NaPi-IIa and NaPi-IIb by B-RAF.

SLC34A2 BRAF

5.45e-053149224258620
Pubmed

The nuclear import of the small GTPase Rac1 is mediated by the direct interaction with karyopherin alpha2.

ARHGEF7 TOP2A ARHGEF6

6.00e-0518149319961560
Pubmed

ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1.

ABCC3 P4HA2 EMC1 ACLY ESYT1 RNF213 GLB1L2 RRM1 PLXNB2 LRP10 SURF4 PPM1L CTSD CPVL SLC37A4 CHST3

6.13e-0512011491635696571
Pubmed

Construction of long-transcript enriched cDNA libraries from submicrogram amounts of total RNAs by a universal PCR amplification method.

PRAMEF7 P4HA2 PRAMEF33 PRAMEF10 POLR2B RTN4IP1 PRAMEF17 GLB1L2 PRAMEF8 WDFY4 KNOP1 BRAF AGA ARHGEF6 NCKAP1L

6.91e-0510841491511544199
Pubmed

Proteomic identification of common SCF ubiquitin ligase FBXO6-interacting glycoproteins in three kinds of cells.

EMC1 POLR2B NRROS RRM1 PLXNB2 ARAF AGA SLC25A1 PRKDC CTSD CPVL

7.18e-056131491122268729
Pubmed

Prediction of the coding sequences of unidentified human genes. XVIII. The complete sequences of 100 new cDNA clones from brain which code for large proteins in vitro.

RNF213 VAT1L WDFY4 MED12L DNAH5

7.68e-05101149510997877
Pubmed

E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins.

VIL1 CACNA1F ANK1 ACLY SLC5A7 TIGD4 RNF213 OR2K2 RNF123 TMEM160 ASNS PRKDC

8.36e-057361491229676528
Pubmed

Activation of mitogen-activated protein kinase/extracellular signal-regulated kinase kinase by G protein and tyrosine kinase oncoproteins.

ARAF BRAF

1.09e-04414928394352
Pubmed

Novel eukaryotic enzymes modifying cell-surface biopolymers.

NXPE4 CPED1

1.09e-044149220056006
Pubmed

Selective activation of MEK1 but not MEK2 by A-Raf from epidermal growth factor-stimulated Hela cells.

ARAF BRAF

1.09e-04414928621729
Pubmed

Aberrant expression of COT is related to recurrence of papillary thyroid cancer.

ARAF BRAF

1.09e-044149225674762
Pubmed

PAK kinases are directly coupled to the PIX family of nucleotide exchange factors.

ARHGEF7 ARHGEF6

1.09e-04414929659915
Pubmed

P53, MAPK, topoisomerase II alpha and Ki67 immunohistochemical expression and KRAS/BRAF mutation in ovarian serous carcinomas.

BRAF TOP2A

1.09e-044149223388101
Pubmed

A tyrosine-phosphorylated protein that binds to an important regulatory region on the cool family of p21-activated kinase-binding proteins.

ARHGEF7 ARHGEF6

1.09e-044149210428811
Pubmed

Obscurin and KCTD6 regulate cullin-dependent small ankyrin-1 (sAnk1.5) protein turnover.

CUL3 ANK1

1.09e-044149222573887
Pubmed

The Cool-2/alpha-Pix protein mediates a Cdc42-Rac signaling cascade.

ARHGEF7 ARHGEF6

1.09e-044149215649357
Pubmed

B-Raf protein isoforms interact with and phosphorylate Mek-1 on serine residues 218 and 222.

ARAF BRAF

1.09e-04414927731720
Pubmed

A targeted next-generation sequencing panel reveals novel mutations in Japanese patients with primary ciliary dyskinesia.

DNAI1 DNAH5

1.09e-044149228939216
Pubmed

Exome sequencing in seven families and gene-based association studies indicate genetic heterogeneity and suggest possible candidates for fibromuscular dysplasia.

DYNC2H1 RNF213

1.09e-044149226147384
Pubmed

Interaction of alphaPIX (ARHGEF6) with beta-parvin (PARVB) suggests an involvement of alphaPIX in integrin-mediated signaling.

ARHGEF7 ARHGEF6

1.09e-044149212499396
Pubmed

Functional characterization of a PROTAC directed against BRAF mutant V600E.

ARAF BRAF

1.09e-044149232778845
Pubmed

The Cbl proteins are binding partners for the Cool/Pix family of p21-activated kinase-binding proteins.

ARHGEF7 ARHGEF6

1.09e-044149212935897
Pubmed

DNAI2 mutations cause primary ciliary dyskinesia with defects in the outer dynein arm.

DNAI1 DNAH5

1.09e-044149218950741
Pubmed

Class 4 Semaphorins and Plexin-B receptors regulate GABAergic and glutamatergic synapse development in the mammalian hippocampus.

SEMA4D PLXNB2

1.09e-044149229981480
Pubmed

Novel regulatory mechanisms for the Dbl family guanine nucleotide exchange factor Cool-2/alpha-Pix.

ARHGEF7 ARHGEF6

1.09e-044149215306850
Pubmed

KLK3/PSA and cathepsin D activate VEGF-C and VEGF-D.

KLK3 CTSD

1.09e-044149231099754
Pubmed

Plexin-B family members demonstrate non-redundant expression patterns in the developing mouse nervous system: an anatomical basis for morphogenetic effects of Sema4D during development.

SEMA4D PLXNB2

1.09e-044149215147296
Pubmed

Expanding functions of GIT Arf GTPase-activating proteins, PIX Rho guanine nucleotide exchange factors and GIT-PIX complexes.

ARHGEF7 ARHGEF6

1.09e-044149227182061
Pubmed

The plexin-B1/Rac interaction inhibits PAK activation and enhances Sema4D ligand binding.

SEMA4D ARHGEF6

1.09e-044149211937491
Pubmed

The GAS6-AXL signaling network is a mesenchymal (Mes) molecular subtype-specific therapeutic target for ovarian cancer.

GAS6 PRKDC

1.09e-044149227703030
Pubmed

Characterization of the zinc-induced Shank3 interactome of mouse synaptosome.

ZAN NCKAP1 ACLY SLC25A1 MYO15A

1.10e-04109149529111324
Pubmed

Network organization of the human autophagy system.

CUL3 SRM AMBRA1 NEDD4 TMEM160 ASNS PRKDC TRMT61B CPVL

1.19e-04437149920562859
Cytoband1p36.21

PRAMEF7 PRAMEF33 PRAMEF10 PRAMEF17 PRAMEF8

2.03e-066314951p36.21
Cytoband10q22.1

HKDC1 NUDT13 AIFM2 CHST3

1.56e-0546149410q22.1
CytobandEnsembl 112 genes in cytogenetic band chr1p36

PRAMEF7 PRAMEF33 EMC1 PRAMEF10 SRM PRAMEF17 PRAMEF8 MFN2 RERE

4.09e-046811499chr1p36
GeneFamilyPRAME family

PRAMEF7 PRAMEF10 PRAMEF17 PRAMEF8

1.12e-05241074686
GeneFamilyDyneins, axonemal

DNAH1 DNAI1 DNAH5

1.29e-04171073536
GeneFamilyMitogen-activated protein kinase kinase kinases|RAF family

ARAF BRAF

3.43e-04510721157
GeneFamilyGuanylate cyclase receptors

GUCY2C GUCY2F

7.15e-0471072343
GeneFamilyOxysterol binding proteins|Pleckstrin homology domain containing

OSBP OSBP2

2.20e-03121072670
GeneFamilySolute carriers

SLC5A7 SLC34A2 SLC25A30 SLC22A18 SLC25A43 SLC22A14 SLC25A1 SLC37A4

2.40e-033951078752
CoexpressionGSE1925_CTRL_VS_3H_IFNG_STIM_MACROPHAGE_DN

COL19A1 SLC34A2 DUOX2 BCHE NUDT13 CD1C BRAF SLC37A4 CHST3

2.06e-061991489M6290
CoexpressionGSE360_T_GONDII_VS_B_MALAYI_HIGH_DOSE_MAC_UP

P4HA2 ANK1 NCKAP1 KALRN SRM MBD3 CD1C SLC25A1

1.82e-051991488M5254
CoexpressionDESCARTES_ORGANOGENESIS_SCHWANN_CELL_PRECURSOR

PRAMEF7 PRAMEF33 PRAMEF10 PRAMEF17 PRAMEF8 ENTPD2

2.01e-05981486MM3656
CoexpressionINGRAM_SHH_TARGETS_UP

PRAMEF7 PRAMEF33 PRAMEF10 PENK PRAMEF17 PRAMEF8 BMP5

3.06e-051561487MM550
CoexpressionKINNEY_DNMT1_METHYLATION_TARGETS

PRAMEF7 PRAMEF10 PRAMEF17 PRAMEF8

3.97e-05341484MM955
CoexpressionPUJANA_XPRSS_INT_NETWORK

NSD2 POLR2B RRM1 CD1C UBE2S PRKDC TOP2A

4.91e-051681487M18811
CoexpressionYAMAZAKI_TCEB3_TARGETS_DN

PRAMEF7 PRAMEF33 PRAMEF10 ACLY PRAMEF17 PRAMEF8 UBE2S TOP2A

5.43e-052321488MM1019
CoexpressionMITSIADES_RESPONSE_TO_APLIDIN_DN

CUL3 NSD2 ACLY POLR2B RRM1 PRKDC SLC37A4 TOP2A

9.15e-052501488M11318
CoexpressionGSE13887_ACT_CD4_VS_NO_TREATED_CD4_TCELL_UP

CLDN14 SLC5A7 NTNG1 SLC22A18 CFAP52 MYO15A

9.41e-051291486M481
CoexpressionKOHOUTEK_CCNT2_TARGETS

PRAMEF7 PRAMEF33 PRAMEF10 PRAMEF17 PRAMEF8

9.73e-05811485MM938
CoexpressionGSE29615_CTRL_VS_DAY7_LAIV_FLU_VACCINE_PBMC_UP

NTNG1 CHI3L1 OR2K2 SURF4 RHOF MORN5 TOP2A

1.21e-041941487M4918
CoexpressionGSE3982_BCELL_VS_EFF_MEMORY_CD4_TCELL_DN

TRPC7 NCKAP1 PENK CHI3L1 RRM1 CIT OR3A1

1.29e-041961487M5543
CoexpressionGSE2706_UNSTIM_VS_8H_R848_DC_UP

P4HA2 ESYT1 MFSD12 SLC22A18 FOXB1 YIF1B CPVL

1.37e-041981487M4693
CoexpressionGSE9650_EFFECTOR_VS_MEMORY_CD8_TCELL_UP

RRM1 LRP10 TMEM160 SURF4 MED12L CTSD TOP2A

1.42e-041991487M5836
CoexpressionGSE360_CTRL_VS_L_MAJOR_DC_UP

ACLY RRM1 CD1C NRXN3 RERE USH2A CPVL

1.42e-041991487M5145
CoexpressionGSE22443_NAIVE_VS_ACT_AND_IL12_TREATED_CD8_TCELL_DN

CUL3 ABCC3 FSCN3 SGTA MFSD12 GUCY2C ASNS

1.46e-042001487M8225
CoexpressionGSE43863_TH1_VS_LY6C_LOW_CXCR5NEG_EFFECTOR_CD4_TCELL_UP

TTC39C PENK VPS36 RRM1 TMEM160 UBE2S TOP2A

1.46e-042001487M9767
CoexpressionGSE17721_POLYIC_VS_GARDIQUIMOD_4H_BMDC_UP

ACADS WNT11 NUDT13 RNF123 ASNS PRKDC RERE

1.46e-042001487M4021
CoexpressionGSE9006_TYPE_1_DIABETES_AT_DX_VS_1MONTH_POST_DX_PBMC_UP

AMBRA1 ARAF TMEM160 MFN2 UBE2S PRKDC CTSD

1.46e-042001487M5783
ToppCellfacs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

CACNA1F ANK1 COL19A1 ZAN KALRN MYO7B PKHD1L1 DNAH1 GUCY2F MYO15A DNAH5 USH2A

1.49e-12184149122cbed6462fea2622871bb7e49b0df3d984239281
ToppCellfacs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

CACNA1F ANK1 COL19A1 ZAN KALRN MYO7B PKHD1L1 DNAH1 GUCY2F MYO15A DNAH5 USH2A

1.49e-1218414912ea7a7e2bac46d4d2c31a5d576b38a032b5335062
ToppCellfacs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

CACNA1F ANK1 COL19A1 ZAN KALRN MYO7B PKHD1L1 DNAH1 GUCY2F MYO15A DNAH5 USH2A

1.49e-12184149122b19a8c5f823e00812908b23e66bb4e563278aff
ToppCellsevere-cDC|severe / Cohort 1 (10x PBMC) with disease condition, cell group and cell class

GAS6 NRROS PLXNB2 CPED1 WDFY4 CD1C YIF1B SERPINF2 CPVL

2.58e-08200149926e04ea276dbca5cde48335c401269c7123b54d2
ToppCellfacs-Marrow-KLS-24m-Myeloid|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

CACNA1F PPAN NMRAL1 SRM YIF1B AGA MORN5 TOP2A

1.39e-071751498f60167473be62d0ef86ce3614e63c0d1377e45b9
ToppCell3'-GW_trimst-1.5-SmallIntestine-Hematopoietic-Myeloid-Monocytes|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

GAS6 SLC25A30 PLXNB2 WDFY4 CD1C CCR1 LRRC14 CPVL

2.51e-071891498a010f3e4da6e9bb23b0b9a7f82ad5cee4e607ecd
ToppCellfacs-Diaphragm-Limb_Muscle-24m|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

COL19A1 ZAN PKHD1L1 DNAH1 NRXN3 DNAH5 USH2A

1.67e-06169149712bdc709bc000d7f9061ecd9fbd57233eaacb7e2
ToppCellwk_20-22-Hematologic-Meg-ery-Megakaryocyte|wk_20-22 / Celltypes from embryonic and fetal-stage human lung

VIL1 ABCC3 KALRN PKHD1L1 SPX MED12L OSBP2

1.74e-061701497eace4dd09cdbde0fa40a6aa0f3dba1114d0ce475
ToppCell3'-GW_trimst-2-SmallIntestine-Mesenchymal-mesothelial_cell|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

GAS6 MUC16 SLC34A2 BCHE CHI3L1 PKHD1L1 OR6N1

2.45e-061791497056df2aaff750e0e283e7da78fcc3c90c366aac0
ToppCell3'-GW_trimst-2-SmallIntestine-Mesenchymal-mesothelial_cell-Mesothelium|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

GAS6 MUC16 SLC34A2 BCHE CHI3L1 PKHD1L1 OR6N1

2.45e-061791497f5f3945ef3b9efc5921a71fd51deeb2c80f0ce11
ToppCellmild-Myeloid-mDC|mild / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs

GAS6 NRROS PLXNB2 CPED1 CD1C YIF1B CPVL

2.93e-0618414978b37c00d59d9992d3b43268991da7bb94646c70e
ToppCellcontrol-Others|control / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs

VIL1 ABCC3 NCKAP1 PKHD1L1 SPX GSTM5 OSBP2

2.93e-061841497a63b39fcc570b554cf10e8e47c2c1e079034768f
ToppCellsevere-Others|severe / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs

ABCC3 ANK1 NCKAP1 PKHD1L1 SPX GSTM5 OSBP2

3.15e-061861497234a4bc7c3529daf8804f2a366887d02a47075cd
ToppCellsystemic_lupus_erythematosus-flare-Myeloid-conventional_dendritic_cell|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex

GAS6 NRROS CPED1 CD1C YIF1B SERPINF2 CPVL

3.63e-0619014974b25d49f033bbd326b47cf5602af3f0262cfc367
ToppCellsystemic_lupus_erythematosus-flare-Myeloid-conventional_dendritic_cell-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex

GAS6 NRROS CPED1 CD1C YIF1B SERPINF2 CPVL

3.89e-0619214978e606eae3e5b07a856d3c2a74186d486da96309c
ToppCellPBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Myeloid-Dendritic|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k)

GAS6 CPED1 WDFY4 CD1C YIF1B SERPINF2 CPVL

4.30e-0619514974cbc36fb3ef9aef61367d3b37070a9a85fae1418
ToppCellFetal_brain-fetalBrain_Zhong_nature-GW08-Myeloid-Microglia|GW08 / Sample Type, Dataset, Time_group, and Cell type.

ANK1 RNF213 NRROS CPED1 WDFY4 CCR1 ARHGEF6

4.45e-06196149789a0ccd0684777927d99d5fc5b7c498f3f124250
ToppCellFetal_brain-fetalBrain_Zhong_nature-GW08-Myeloid|GW08 / Sample Type, Dataset, Time_group, and Cell type.

ANK1 RNF213 NRROS CPED1 WDFY4 CCR1 ARHGEF6

4.45e-06196149791a8c4798572d6c1f03cef5e8e5464ed0046c7cf
ToppCellPBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Myeloid-Dendritic-conventional_dendritic_cell|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k)

GAS6 CPED1 WDFY4 CD1C YIF1B SERPINF2 CPVL

4.76e-06198149708ad0bece508bb4f9cc126d94839b5c89ce21ba8
ToppCellLPS_only-Epithelial_airway-airway_epithelial|LPS_only / Treatment groups by lineage, cell group, cell type

PENK DUOX2 DNAH1 DNAI1 CFAP52 FUT2 DNAH5

4.76e-061981497e035380578c01b0243bfef29ca9b50cc17cce771
ToppCellLPS_only-Epithelial_airway|LPS_only / Treatment groups by lineage, cell group, cell type

PENK DUOX2 DNAH1 DNAI1 CFAP52 FUT2 DNAH5

4.76e-061981497ba090210392e001a3f7bdf09371b3f0e0c8c7ef3
ToppCellBronchial-NucSeq-Immune_Myeloid-Macrophage_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

ABCC3 MYO7B WDFY4 OR6N1 CPVL TNS3 NCKAP1L

5.08e-062001497a443e475e7a10c26a6173d1af961de6219e0e567
ToppCellcontrol-cDC|control / Cohort 1 (10x PBMC) with disease condition, cell group and cell class

GAS6 CPED1 WDFY4 CD1C YIF1B SERPINF2 CPVL

5.08e-0620014974a6d17a4225be38537d3dd8a39512051f597f4e0
ToppCellBronchial-NucSeq-Immune_Myeloid-Macrophage_alveolar-Macro_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

ABCC3 MYO7B WDFY4 OR6N1 CPVL TNS3 NCKAP1L

5.08e-062001497ed785a6d08ca2b350dc3307b587eadfb2886d1f9
ToppCellmild-cDC|mild / Cohort 1 (10x PBMC) with disease condition, cell group and cell class

GAS6 NRROS WDFY4 CD1C YIF1B SERPINF2 CPVL

5.08e-062001497d6409ee5b9067be3dd2f852825e09151b5b22d7c
ToppCellLPS_only-Epithelial_airway-Ciliated_cells-Ciliated|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

DNAH1 DNAI1 CFAP52 DNAH5 USH2A MORN5

1.34e-0515414969ca71d440c4f87781e6525b8141e7d8d470b6a8e
ToppCellLPS_only-Epithelial_airway-Ciliated_cells|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

DNAH1 DNAI1 CFAP52 DNAH5 USH2A MORN5

1.34e-05154149658072ce422d09f2de602580325eaac6c4ec6c136
ToppCellLPS-IL1RA+antiTNF-Epithelial_airway-Ciliated_cells|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

DUOX2 GLB1L2 DNAH1 DNAI1 CFAP52 DNAH5

1.39e-0515514965f1e2195a6b831e1b636f5cc3a282ca423721822
ToppCellLPS-IL1RA+antiTNF-Epithelial_airway-Ciliated_cells-Ciliated|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

DUOX2 GLB1L2 DNAH1 DNAI1 CFAP52 DNAH5

1.39e-0515514960944429459f642a1bcc56edc1ec28aaecde3e2dc
ToppCellfacs-Lung-24m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_type_1_endothelial_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

ZAN DUOX2 PKHD1L1 GUCY2F LGR6 USH2A

1.78e-051621496bf886e22ff2a20353499004b53f25fb9e6574896
ToppCellLPS-IL1RA+antiTNF-Epithelial_airway|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

PENK DUOX2 DNAH1 DNAI1 CFAP52 DNAH5

1.91e-051641496e4d4c59aebe5cacd4ecdb907facd044dc82a831d
ToppCellPBMC-Mild-Hematopoietic-Platelet-Platelet-plt_0|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)

ABCC3 ANK1 NCKAP1 SLC5A7 PKHD1L1 OSBP2

1.98e-0516514966799a6580c667738995cceb31cbf1c7fbdc4ff84
ToppCellPBMC-Mild-Hematopoietic-Platelet-Platelet-plt_0|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

ABCC3 ANK1 NCKAP1 SLC5A7 PKHD1L1 OSBP2

1.98e-0516514968329d780f244bc31344443b29e5a00529a016662
ToppCelldroplet-Liver-HEPATOCYTES-1m-Epithelial-Hepatocyte_(Pericentral_and_Periportal)|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

ACLY FOXA2 SLC25A1 SERPINF2 SLC37A4 TAT

1.98e-051651496d449a568664a81d9b5538e8f409301448a32ac37
ToppCellNS-control-d_0-4-Myeloid-pDC|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)

CCDC168 NRROS CPED1 WDFY4 MED12L SERPINF2

1.98e-0516514968b2d43d7c4ee07bd999bd51bc15117ce1fbb2d86
ToppCellcontrol-Myeloid-pDC|control / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls

CCDC168 NRROS CPED1 WDFY4 MED12L SERPINF2

1.98e-051651496243c74adf8d993ff92acbff2768bdc5a1693eca3
ToppCell390C-Lymphocytic-Plasma_cell|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)

CLDN14 NXPE4 GAS6 NTNG1 PKHD1L1 TTLL7

2.05e-0516614964ba3711a02d3695b27f7cefd7c60e3be009f5bef
ToppCell390C-Lymphocytic-Plasma_cell-|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)

CLDN14 NXPE4 GAS6 NTNG1 PKHD1L1 TTLL7

2.05e-05166149635f6ae2664935dda0d883b32a050ced843204f2d
ToppCellfacs-Kidney-nan-24m-Lymphocytic-B_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation

ANK1 VAT1L WDFY4 CPVL RHOF CHST3

2.12e-0516714963c4183a8225bae37b9f5341ebd1b95409ced2022
ToppCellfacs-Kidney-nan-24m-Lymphocytic-B_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation

ANK1 VAT1L WDFY4 CPVL RHOF CHST3

2.12e-05167149628e9670586ff551b700c794313d27eedbfa1286b
ToppCellPND03-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT2-AT2_prolif|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

SGTA HKDC1 SLC34A2 RRM1 SLC25A1 VCPIP1

2.19e-05168149608f6e171a1ea5cf65149744296d0fcd6c7b9684e
ToppCellfacs-Lung-EPCAM-3m-Epithelial-club_cell_of_bronchiole|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

FSTL5 FOXA2 MFSD12 CFAP52 MYO15A DNAH5

2.34e-05170149682ccba6ec53f6ca0d19949a1277434c565af2983
ToppCellfacs-Lung-EPCAM-3m-Epithelial-Club_Cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

FSTL5 FOXA2 MFSD12 CFAP52 MYO15A DNAH5

2.34e-051701496ab19ea729ed8c8361c870e79893d1a95a1e487fa
ToppCelldroplet-Lung-LUNG-30m-Lymphocytic-regulatory_T_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

TTC39C NTNG1 MSTN FOXB1 CPVL RHOF

2.50e-0517214964d04df9776394ea156ed5822f92ae74fdefbaa3d
ToppCelldroplet-Lung-LUNG-30m-Lymphocytic-Regulatory_T|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

TTC39C NTNG1 MSTN FOXB1 CPVL RHOF

2.50e-0517214963acf35b774ebc0f9e96299d0bd3e9d03bbf6b90c
ToppCelldroplet-Spleen-SPLEEN|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

ANK1 CHI3L1 GSTM5 ASNS CTSD TOP2A

2.50e-051721496d32731a56e113ff0ef7167b23959d69baf2068f9
ToppCellprimary_visual_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Ptprt_Pkp2|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype

FSTL5 PENK SLC5A7 BCHE GLB1L2 CIT

2.84e-05176149605ec715439f2eb1696f5d8855da0dd1dd70effd0
ToppCellIIH-mDC1-|IIH / Condition, Cell_class and T cell subcluster

MYO7B WDFY4 FOXB1 SLC22A14 SERPINF2 CPVL

2.84e-051761496bb80a3e595d071f6cc8b042984b8d9490e377eef
ToppCellIIH-mDC1|IIH / Condition, Cell_class and T cell subcluster

MYO7B WDFY4 FOXB1 SLC22A14 SERPINF2 CPVL

2.84e-051761496a75dc132a1061006fd1cb305bd314784fca07ea6
ToppCellMid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L6_LHX6_GLP1R|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

ANK1 PENK SLC5A7 BCHE PRAMEF17 CPED1

2.94e-0517714962b675840b7d2bb536c2c600936733bd9e97e7120
ToppCell3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

DYNC2H1 GLB1L2 TTLL7 DNAH1 DNAI1 DNAH5

3.22e-05180149692fb01b91261b3103454924cde56add337b41844
ToppCellPBMC_fresh-frozen-Severe-critical_convalescent_d14-21-Myeloid-Dendritic-conventional_dendritic_cell-DC_c2-CD1C|Severe-critical_convalescent_d14-21 / Compartment, severity and other cell annotations on 10x 3' data (130k)

NRROS PLXNB2 WDFY4 CD1C YIF1B CPVL

3.22e-0518014962bc3fd2e4c249bf236340c5f0483747faa5c04ec
ToppCellPBMC_fresh-frozen-Severe-critical_convalescent_d14-21-Myeloid-Dendritic-conventional_dendritic_cell|Severe-critical_convalescent_d14-21 / Compartment, severity and other cell annotations on 10x 3' data (130k)

NRROS PLXNB2 WDFY4 CD1C YIF1B CPVL

3.33e-0518114961b4eb044825ede6361928442524b1988c8ef58b3
ToppCellPBMC_fresh-frozen-Severe-critical_convalescent_d14-21-Myeloid-Dendritic|Severe-critical_convalescent_d14-21 / Compartment, severity and other cell annotations on 10x 3' data (130k)

NRROS PLXNB2 WDFY4 CD1C YIF1B CPVL

3.33e-0518114968d7ebbedc373d55e29da02ac2728b4f4118038f2
ToppCellPBMC_fresh-frozen-Severe-critical_progression_d03-09-Myeloid-Dendritic-conventional_dendritic_cell-DC_c2-CD1C|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k)

GAS6 PLXNB2 WDFY4 CD1C YIF1B CPVL

3.33e-051811496c8286a7ac8e3cc5aa7e92b043a08435294ea686f
ToppCellHippocampus-Neuronal-Inhibitory|Hippocampus / BrainAtlas - Mouse McCarroll V32

ANK1 COL19A1 FSTL5 CIT ARAF NRXN3

3.43e-051821496b54ae650c04dfd0759c5f5e752b9bf684dd36516
ToppCell5'-Adult-LargeIntestine-Mesenchymal-myocytic-myofibroblast_(RSPO2+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract

COL19A1 BCHE VAT1L CPED1 NRXN3 MORN5

3.54e-05183149661a73de857f4ae02dcba3af348f436f602b28ff2
ToppCell10x3'2.3-week_17-19-Hematopoietic-MK-MK|week_17-19 / cell types per 3 fetal stages;per 3',per 5'

ABCC3 KALRN PKHD1L1 SPX YIF1B MED12L

3.65e-051841496ba65e3972b2b8d825a2c1a9d03d092cc1afad073
ToppCellcontrol-Others-Megakaryocytes|control / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs

VIL1 ABCC3 NCKAP1 PKHD1L1 SPX OSBP2

3.65e-051841496213915f2889ce8ecbe5f7b19bc2b24ed8c5efe1d
ToppCellfacs-Brain_Non-Myeloid-Cerebellum-24m-Epithelial-neuroepithelial_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation

TIGD4 DNAH1 DNAI1 CFAP52 DNAH5 TAT

3.76e-05185149605bc89a566b0db90ae06506e067190a4739a0974
ToppCellCiliated_cells-B-Myositis-ILD_01|World / lung cells shred on cell class, cell subclass, sample id

DYNC2H1 MUC16 DNAI1 CFAP52 DNAH5 MORN5

3.76e-051851496f012c243343e1d1956db19b34d062e9b13de2b2a
ToppCelltumor_Lung-Epithelial_cells-tS3|Epithelial_cells / Location, Cell class and cell subclass

COL19A1 TTLL7 DNAI1 CFAP52 DNAH5 MORN5

3.99e-0518714963cea677279e71fdb9879530dea10a5e6393beacd
ToppCellsevere-Others-Megakaryocytes|severe / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs

ABCC3 ANK1 NCKAP1 PKHD1L1 SPX OSBP2

3.99e-051871496ef16331d1e5abe6bde7f09793c4a87a6ac24e592
ToppCellPBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Myeloid-Monocytic-Nonclassical_Monocyte-Mono_c5-CD16|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k)

P4HA2 MFSD12 CD1C CCR1 CTSD CPVL

3.99e-0518714965917bdfe84cf5941e21b415aebbab3090cc5d576
ToppCell3'_v3-blood-Myeloid_Dendritic|blood / Manually curated celltypes from each tissue

ZAN GAS6 WDFY4 CD1C SERPINF2 CPVL

4.11e-051881496239a2162a21d3339da7c1884ab76286346fbf97f
ToppCellsevere_COVID-19-Plasmablast|World / disease group, cell group and cell class (v2)

CLDN14 GAS6 PKHD1L1 AIFM2 ASNS TOP2A

4.11e-05188149625ca19af4ac419a0f5026a6ccbd8b554b268a6f3
ToppCellFetal_29-31_weeks-Mesenchymal-airway_smooth_muscle_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor

WNT11 GAS6 MC2R BCHE MBD3 LGR6

4.11e-051881496c29aaae3c5bb7cd6b9b3defd4d27afde3af19ba0
ToppCell10x5'v1-week_17-19-Hematopoietic|week_17-19 / cell types per 3 fetal stages;per 3',per 5'

ANK1 KALRN PKHD1L1 SPX GSTM5 MED12L

4.11e-051881496c00ba0abd0c7bb2c8f9166a2ac6220aae4f4d857
ToppCell5'-Adult-SmallIntestine-Mesenchymal-myocytic-myofibroblast_(RSPO2+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract

COL19A1 BCHE VAT1L CPED1 TTLL7 NRXN3

4.11e-051881496879de94924de978478696fc7838e05a4d795b905
ToppCell5'-Adult-SmallIntestine-Mesenchymal-myocytic|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract

COL19A1 BCHE VAT1L CPED1 TTLL7 NRXN3

4.23e-051891496ab7ece0a517499b70b7754720d3e434765363af6
ToppCellAdult|World / Lineage, Cell type, age group and donor

ABCC3 HKDC1 SLC34A2 RNF213 NRXN3 DNAH5

4.23e-0518914965cd285bfad973125d46d704fec18b21266a63379
ToppCell10x_3'_v2v3-Non-neoplastic-Myeloid-Mono-Mono_anti-infl-A|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group

ABCC3 NUDT13 DNAH1 SERPINF2 BAHCC1 NCKAP1L

4.36e-05190149663018acb7ad80415e861643162abdc2e55968ee4
ToppCelldroplet-Lung-nan-18m-Epithelial|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

HKDC1 SLC34A2 CHI3L1 FOXA2 DNAH1 CFAP52

4.36e-051901496b057bea6e55cef872290893b6e439bbcdcee2f2e
ToppCellBAL-Control-Epithelial-Epithelial-Ciliated|Control / Location, Disease Group, Cell group, Cell class (2021.03.09)

MUC16 SLC34A2 DNAI1 CFAP52 DNAH5 MORN5

4.49e-0519114967b5da29109aa28768c67653a1bc0f385c2d2269b
ToppCellBAL-Control-Epithelial|Control / Location, Disease Group, Cell group, Cell class (2021.03.09)

MUC16 SLC34A2 DNAI1 CFAP52 DNAH5 MORN5

4.49e-0519114969f19098f260d5542aa8ba7eb6f91b44d0db6e0a4
ToppCellBAL-Control-Epithelial-Epithelial-Ciliated-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

MUC16 SLC34A2 DNAI1 CFAP52 DNAH5 MORN5

4.49e-051911496fa9f8b50bfc7911c858bc2f9dcd204873d97ac61
ToppCellControl-Epithelial-Ciliated_cells|Control / Condition, Lineage and Cell class

MUC16 SLC34A2 DNAI1 CFAP52 DNAH5 MORN5

4.49e-051911496ea1d2c6838119b7019e9a2ff71d6212262b51b57
ToppCellBAL-Control-Epithelial-Epithelial-Ciliated-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)

MUC16 SLC34A2 DNAI1 CFAP52 DNAH5 MORN5

4.49e-051911496b4e335e798c9617356b8e24412f9270c42dce656
ToppCellBAL-Control-Epithelial-Epithelial-Ciliated|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

MUC16 SLC34A2 DNAI1 CFAP52 DNAH5 MORN5

4.49e-051911496c4b223b33c020a064f576711a3d700eb60a2d737
ToppCellBAL-Control-Epithelial|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

MUC16 SLC34A2 DNAI1 CFAP52 DNAH5 MORN5

4.49e-0519114965129f778a9283bfac4ff322c21c5ca71da4b7174
ToppCellBAL-Control-Epithelial-Epithelial|Control / Location, Disease Group, Cell group, Cell class (2021.03.09)

MUC16 SLC34A2 DNAI1 CFAP52 DNAH5 MORN5

4.49e-051911496df8a1a6e78aa0cb941b94cb676bd6891d79f3687
ToppCell10x5'v1-week_14-16-Hematopoietic-MK|week_14-16 / cell types per 3 fetal stages;per 3',per 5'

KALRN WNT11 PKHD1L1 SPX GSTM5 MED12L

4.49e-0519114967edc22e7e70697fb22690699efb352577162709b
ToppCellControl-Epithelial|Control / Disease group,lineage and cell class （2021.01.30）

MUC16 SLC34A2 DNAI1 CFAP52 DNAH5 MORN5

4.49e-051911496b78547dae8328244a47c83346447bdd787efbcae
ToppCellBAL-Control-Epithelial-Epithelial|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

MUC16 SLC34A2 DNAI1 CFAP52 DNAH5 MORN5

4.49e-051911496c50d6a1a6209ed4157f7c00fc24d4ecb43790f44
ToppCellControl-Epithelial-Ciliated|Control / Disease group,lineage and cell class （2021.01.30）

MUC16 SLC34A2 DNAI1 CFAP52 DNAH5 MORN5

4.49e-051911496cdc08e95a0c8f5c7a8d01b6bbaafdb54ef2f0d12
ToppCellControl-Epithelial|Control / Condition, Lineage and Cell class

MUC16 SLC34A2 DNAI1 CFAP52 DNAH5 MORN5

4.49e-0519114966228302febdb3dffe37dece7062d27ac9ccc6d4b
ToppCellnucseq-Epithelial-Epithelial_Airway|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2

DYNC2H1 MUC16 DNAI1 CFAP52 DNAH5 MORN5

4.49e-0519114961c528f72c9ef3ef3a850b05e4a9715190832270c
ToppCell10x5'v1-week_14-16-Hematopoietic-MK-MK|week_14-16 / cell types per 3 fetal stages;per 3',per 5'

ABCC3 KALRN WNT11 PKHD1L1 SPX MED12L

4.62e-051921496b877d14be9d04ab0010e340909e3a23de92613db
ToppCellrenal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

KALRN CPED1 TTLL7 NRXN3 ARHGEF7 LGR6

4.62e-051921496bfab13793e54de2550ee171397f7ece0625cdb4a
ToppCellrenal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

KALRN CPED1 TTLL7 NRXN3 ARHGEF7 LGR6

4.62e-051921496b54b0d5b88139905521c8d5d58332e89c08d589c
ToppCellcellseq-Immune-Immune_Myeloid-Myeloid_Dendritic-cDC1|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2

WDFY4 CD1C FOXB1 SERPINF2 CPVL RHOF

4.62e-0519214963674c81aeee6f055cfa854d9429c1b7f5789d0fc
ToppCellsystemic_lupus_erythematosus-treated-Myeloid-conventional_dendritic_cell|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex

GAS6 NRROS CD1C YIF1B SERPINF2 CPVL

4.76e-051931496984ea5b871479527ab57dd813bacae844c0d8c06
ToppCellsystemic_lupus_erythematosus-treated-Myeloid-conventional_dendritic_cell-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex

GAS6 NRROS CD1C YIF1B SERPINF2 CPVL

4.76e-051931496529281b912070c8655e38880ac73f5e4bd6ee4ce
ToppCell3'-Broncho-tracheal-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

GAS6 MC2R BCHE MSTN GSTM5 LGR6

4.90e-05194149691205b22650e7ecdb72bb59348ce2530b76c532c
ToppCell3'-Broncho-tracheal-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

GAS6 MC2R BCHE MSTN GSTM5 LGR6

4.90e-0519414966e12a7da35be4c0ecf998ef94b8989b89d74b200
ToppCell3'-Broncho-tracheal-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts-Myofibroblasts_L.2.3.2.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

GAS6 MC2R BCHE MSTN GSTM5 LGR6

4.90e-051941496c52f10140c66e8c0566421c3d535d5d92bf595e1
ToppCellnormal_Lung-Myeloid_cells-CD141+_DCs|Myeloid_cells / Location, Cell class and cell subclass

WDFY4 FOXB1 OSBP2 SERPINF2 CPVL RHOF

4.90e-051941496d21461682fa755f588afe073abb6a777f339c4cc
ToppCell343B|World / Donor, Lineage, Cell class and subclass (all cells)

SLC34A2 CHI3L1 FOXA2 SERPINF2 DNAH5 MORN5

5.04e-0519514962290911fde6efacfa38b985a2541322968bee42d
ToppCell(010)_cDC|World / immune cells in Peripheral Blood (logTPM normalization)

GAS6 NRROS CPED1 WDFY4 CD1C CPVL

5.04e-0519514964aabb3f5ce70100e4d98d7fa9f8d12e84fb9fe3d
ToppCell3'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.2.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

SRM HKDC1 SLC34A2 CHI3L1 ASNS SERPINF2

5.04e-051951496643a360d3358bad52f0737c0d55195b69007c29b
Drugcaracemide

BCHE RRM1 DNAI1 GUCY2C GUCY2F

4.47e-08161485CID000054747
DiseaseAdenocarcinoma of lung (disorder)

PPAN SRM RRM1 ARAF BRAF GUCY2F PRKDC TOP2A

6.34e-062061398C0152013
DiseaseAdrenocortical carcinoma

RRM1 BRAF TOP2A

7.93e-05181393C0206686
DiseaseKartagener syndrome (is_implicated_in)

DNAI1 DNAH5

1.31e-0441392DOID:0050144 (is_implicated_in)
DiseaseMalignant neoplasm of breast

ANK1 COL19A1 KALRN DYNC2H1 ZSWIM5 NSD2 BCHE ARAF NEDD4 SLC22A18 FBXO8 BRAF GUCY2F LGR6 TOP2A

1.72e-04107413915C0006142
Diseasephospholipase D3 measurement

MFSD12 CTSD

3.26e-0461392EFO_0802866
Diseasebacterial meningitis (is_marker_for)

BCHE CHI3L1

4.56e-0471392DOID:9470 (is_marker_for)
DiseaseLung diseases

FOXA2 DNAI1 PRKDC DNAH5

5.13e-04781394C0024115
Diseaseobesity (implicated_via_orthology)

PLXNB2 GSTM5 BMP5 ANGPTL6 GUCY2C MED12L

5.61e-042151396DOID:9970 (implicated_via_orthology)
DiseasePrimary ciliary dyskinesia

DNAH1 DNAI1 DNAH5

6.52e-04361393cv:C0008780
Diseaseplatelet endothelial cell adhesion molecule measurement

BCHE SURF4

7.76e-0491392EFO_0010598
Diseaseasparagine measurement

CPAMD8 AGA ASNS

9.57e-04411393EFO_0009766
DiseaseCongenital myasthenic syndrome

SLC5A7 SLC25A1

9.67e-04101392cv:C0751882
Diseasealpha wave measurement, electroencephalogram measurement

DNAH1 TNS3

9.67e-04101392EFO_0004357, EFO_0006870
DiseaseBreast Carcinoma

DYNC2H1 ZSWIM5 NSD2 BCHE ARAF SLC22A18 BRAF LGR6 TOP2A

1.05e-035381399C0678222
Diseaseinterleukin-6 measurement, response to stimulus

FSTL5 MUC16

1.18e-03111392EFO_0004810, GO_0050896
DiseaseBipolar I disorder

TRPC7 NRXN3

1.18e-03111392C0853193
Diseaselung non-small cell carcinoma (is_marker_for)

NSD2 CHI3L1 RRM1 FOXA2 SLC22A18

1.26e-031691395DOID:3908 (is_marker_for)
DiseasePrimary Ciliary Dyskinesia

DNAH1 DNAI1 DNAH5

1.43e-03471393C4551720
Diseasedevelopmental disorder of mental health (implicated_via_orthology)

NCKAP1 PLXNB2 NCKAP1L

1.61e-03491393DOID:0060037 (implicated_via_orthology)
Diseaseosteitis deformans

GSTM5 SLC25A43

1.66e-03131392EFO_0004261
Diseaseglycochenodeoxycholate glucuronide (1) measurement

ABCC3 SPX

1.66e-03131392EFO_0800474
DiseaseColorectal Carcinoma

ABCC3 CPAMD8 KALRN FSTL5 NTNG1 OSBP BRAF GUCY2C OR1E2 LGR6

1.86e-0370213910C0009402
DiseaseNeoplasm of lung

SLC22A18 BRAF

1.93e-03141392cv:C0024121
DiseaseKartagener syndrome (implicated_via_orthology)

DNAI1 DNAH5

1.93e-03141392DOID:0050144 (implicated_via_orthology)
DiseaseLung cancer

SLC22A18 BRAF

1.93e-03141392cv:C0242379
DiseaseLUNG CANCER

SLC22A18 BRAF

1.93e-03141392211980
DiseaseColorectal Neoplasms

ABCC3 CPAMD8 NTNG1 BRAF GUCY2C LGR6

2.06e-032771396C0009404
DiseaseProstatic Neoplasms

CUL3 PENK MC2R KLK3 BRAF SURF4 PRKDC CTSD TOP2A

2.64e-036161399C0033578
DiseaseMalignant neoplasm of prostate

CUL3 PENK MC2R KLK3 BRAF SURF4 PRKDC CTSD TOP2A

2.64e-036161399C0376358
Diseasetestosterone measurement

VIL1 TRPC7 ZAN UGT2A2 NTNG1 HKDC1 SLC22A18 BMP5 TMEM160 MYO15A SERPINF2 USH2A ARHGEF6 TNS3

2.84e-03127513914EFO_0004908
Diseasecystatin C measurement

KALRN CYP26A1 SRM FNDC3A FOXA2 DNAH1 RNF123

3.03e-034021397EFO_0004617
DiseaseMammary Carcinoma, Human

DYNC2H1 ZSWIM5 NSD2 BCHE ARAF SLC22A18 LGR6 TOP2A

3.52e-035251398C4704874
DiseaseMammary Neoplasms, Human

DYNC2H1 ZSWIM5 NSD2 BCHE ARAF SLC22A18 LGR6 TOP2A

3.52e-035251398C1257931
DiseaseCongenital Myasthenic Syndromes, Presynaptic

SLC5A7 SLC25A1

3.57e-03191392C0751884
DiseaseMammary Neoplasms

DYNC2H1 ZSWIM5 NSD2 BCHE ARAF SLC22A18 LGR6 TOP2A

3.60e-035271398C1458155
Diseaseplatelet measurement

P4HA2 KALRN YIF1B MED12L MFN2 RHOF

3.87e-033151396EFO_0005036
Diseasecoronary artery disease (is_marker_for)

CHI3L1 CCR1 SERPINF2

3.93e-03671393DOID:3393 (is_marker_for)
DiseaseMalignant Glioma

CHI3L1 BRAF TOP2A

4.45e-03701393C0555198
Diseasemixed gliomas

CHI3L1 BRAF TOP2A

4.45e-03701393C0259783
Diseaseobsolete_red blood cell distribution width

CUL3 P4HA2 ANK1 ACADS NRF1 KALRN GAS6 TIGD4 DUOX2 RRM1 CIT RNF123 OSBP2 LRRC14

4.61e-03134713914EFO_0005192

Protein segments in the cluster

PeptideGeneStartEntry
TGKFAPYLSQMSNLR

PRAMEF33

221

A0A0G2JMD5
GRDTYGVRPLFKAMT

ASNS

136

P08243
FQLSSSGPNSRLYMK

ESYT1

576

Q9BSJ8
IFMVGRGYLSPDLSK

BRAF

666

P15056
LPMGLALRKYAGQAE

BAHCC1

2296

Q9P281
SMNYRVGALGFLALP

BCHE

171

P06276
LSASPRMSGFIYQGK

ARHGEF6

481

Q15052
ASYPLGLGMNKISIF

CPED1

631

A4D0V7
GPGAFRLAARMYLQK

SERPINF2

156

P08697
MSVNNSLYLGPILKF

ACADS

116

P16219
PGGSLSFLRKAMKYE

ANK1

1336

P16157
NLLNMAYGVKSPLSL

ELAVL3

241

Q14576
LSASPRMSGFIYQGK

ARHGEF7

511

Q14155
SRGMLLLYSLKNPSF

DNAI1

361

Q9UI46
LGEMLYTKRFGPNAI

AMBRA1

931

Q9C0C7
MLKFKYGARNPLDAG

CIT

1

O14578
IGDAYMVASGLPKRN

GUCY2C

871

P25092
SRPIFGLTSNYKGMT

IWS1

686

Q96ST2
SPANLIAARGIFYGM

ABCC3

1506

O15438
YGGFMRGLKRSPQLE

PENK

186

P01210
MLLKLYGLGPSAYVS

CACNA1F

576

O60840
LGPMFKNTSVGLLYS

MUC16

12891

Q8WXI7
LGYTAATIPKMLANL

OR6N1

71

Q8NGY5
TGKFAPYLSQMSNLR

PRAMEF17

221

Q5VTA0
ARAPMGQGFLLSYSQ

LRP10

121

Q7Z4F1
MAAFGLLSYEQRPLK

MED12L

1

Q86YW9
RPGFSLYKTLAESMG

TAT

166

P17735
GYLRLKMTYLPKTSG

NEDD4

561

P46934
YEKLGFPGARDLANM

NMRAL1

246

Q9HBL8
AYMKSSQFLRGLLFG

GSTM5

196

P46439
KPQLARYLGGSMDLS

MBD3

46

O95983
PGQAFSGLYSLKILM

LGR6

106

Q9HBX8
PKRSLKGTSRLFMGF

MYO15A

26

Q9UKN7
MGLPSYSQALLAFGL

DUOX2

436

Q9NRD8
VGYMLRLGAPASKLV

CHI3L1

241

P36222
GKIRAFAPETGRLMY

CFAP52

396

Q8N1V2
FPGLNMKSYAGFLTV

CPVL

66

Q9H3G5
PLYLGATAGMRLLNL

ENTPD2

116

Q9Y5L3
GSLYAMTQDKVFRLP

PLXNB2

451

O15031
GSGIFNYMRLGSTKL

OR3A1

256

P47881
RIIDAGPKGNYSRFM

NSD2

1126

O96028
FSELLRKGSLTPGYM

KALRN

2156

O60229
MYSNLPKLVASRDGF

NRXN3

1001

Q9Y4C0
RAFIPEMLKYSTGRG

NRF1

206

Q16656
PPLGFSFRKLYMQLD

FBXO8

126

Q9NRD0
AELLGPYGMKFLSEN

NCKAP1L

841

P55160
FLRLMGGFKNLSPSF

KNOP1

376

Q1ED39
RQSSFPKGMYSALAG

NUDT13

216

Q86X67
TSKFRGKYLSIMPLG

OSBP

546

P22059
SKFRGKYISIMPLGA

OSBP2

651

Q969R2
ELLGPYGMKFLSESL

NCKAP1

841

Q9Y2A7
FLGPKNSRRALMGYN

MFN2

556

O95140
GGYGLKSYQPLMRLR

FSTL5

26

Q8N475
IAREYKMPGGLAFSA

FOXB1

176

Q99853
SRGELPGTKYQAMLS

P4HA2

151

O15460
FGSGAFMYLKPLSIL

OR8B12

251

Q8NGG6
RAMAKAGLSNYGNPR

SLC37A4

286

O43826
LMKQRGFYSDILSPG

DNAH1

91

Q9P2D7
GKGMLLRYAFSQLRS

DYNC2H1

2296

Q8NCM8
MVGRGYLSPDLSKIS

ARAF

521

P10398
KALYSGIAPAMLRQA

SLC25A30

66

Q5SVS4
PRFLLGLLDAGKMYV

CD1C

186

P29017
LLPSGMKFEIGQALY

CLDN14

151

O95500
AILASMPGLYFSKTQ

CCR1

161

P32246
GIPFNERNGMSSLYK

COL19A1

816

Q14993
LKLPAAMLAAQAYGR

COL19A1

1041

Q14993
YSFRLRAANKMGFGP

FNDC3A

731

Q9Y2H6
TLYALAKMNGRPAFI

FUT2

81

Q10981
SVKSLYLGRMFSGTP

GAS6

291

Q14393
LGCMYKLFSRVPNGL

CUL3

296

Q13618
IAAKFDGILGMAYPR

CTSD

191

P07339
RARYTFGKPVAGALM

CPAMD8

251

Q8IZJ3
SLGLGDLRVPSSMLY

GPR148

36

Q8TDV2
IGDAYMVASGLPKRN

GUCY2F

931

P51841
GMSALLLPGNFESYL

SDHC

86

Q99643
GSNLLTVLAPNGFYM

FSCN3

461

Q9NQT6
TKNGLSPGMRTCFLY

BCE1

31

O60756
FRGGAYSLRKAAMLI

ANGPTL6

451

Q8NI99
GKQASSAPLFMLDLY

BMP5

71

P22003
ATGNGDILMRFLPSY

AGA

256

P20933
IDVPFSGLYRGMKAR

CYP26A1

226

O43174
PGMRLRTTYKGFTEA

GLB1L2

156

Q8IW92
SGMSSLYVFNPIFGK

EMC1

596

Q8N766
SISYMLNIRAGAGPK

CCDC168

1716

Q8NDH2
LSTLVKFAPYLGQMR

PRAMEF8

216

Q5VWM4
DKMGRYPAILLSLLG

SLC22A14

206

Q9Y267
YLSGFLSSFLMKPIN

MFSD12

321

Q6NUT3
KMLSALLTGVNRAYP

CEBPZ

481

Q03701
LLGSLLSNRYNMPFK

DNAH5

1591

Q8TE73
QYLPDGFLRKMPSLS

NRROS

341

Q86YC3
PFIYSLRNRDMKGAL

OR1E2

296

P47887
PFIYSLRNKDMKGSL

OR7C2

286

O60412
LDSRLKTPMYLFLGN

OR2K2

51

Q8NGT1
MYGQAGLSRARDPKT

FOXA2

136

Q9Y261
FFAGPRLRNMASLYG

NTNG1

231

Q9Y2I2
GKLQSPGNMRFTLYE

POLR1E

31

Q9GZS1
RSGYGATALNMKRDP

RTN4IP1

91

Q8WWV3
IYGKRMGGLLFIPAL

SLC5A7

121

Q9GZV3
LYKTGMNVPGSFILR

USH2A

3061

O75445
LRQMSYGGKFGSSPL

RBM7

151

Q9Y580
GKTSLLMVYSQGSFP

RHOF

31

Q9HBH0
AMLYLKGAQGRRFIS

SPX

41

Q9BT56
PAYSKAYGRMGLALS

SGTA

156

O43765
YKPGALTFLLSMGRN

AIFM2

321

Q9BRQ8
DYMGLKGASLPLGFT

HKDC1

586

Q2TB90
KQYGGDFLRARMSSP

NXPE4

131

Q6UWF7
YTGIRSLKLDMNPGT

MSTN

186

O14793
LAMSRSLGDYPLKNL

PPM1L

261

Q5SGD2
AGPLLAFLFRGMFKN

POLR2B

396

P30876
SSPKQYMQLGGRVLL

SURF4

151

O15260
RTDLYFMPLAGSKLA

RERE

1146

Q9P2R6
PFSAGSLLVYMNLEK

SLC25A43

176

Q8WUT9
AESPKYGLMGRKNLL

SEMA4D

596

Q92854
SFRGAYGLAMKVATP

TNS3

1201

Q68CZ2
FMQFSIVPYLSRKLG

SLC22A18

41

Q96BI1
GMLDNILASKLYRPG

ACLY

641

P53396
LRNMGYLKPRGSFET

MC2R

86

Q01718
QAACGPAMRLFGYKL

CHST3

441

Q7LGC8
PIRMAKGLGNISAKY

SLC34A2

511

O95436
LSTLVKFAPYLGQMR

PRAMEF7

216

Q5VXH5
MQGPAAYSDLFRSLK

RNF213

2786

Q63HN8
MALGGKAPYANTKRL

VIL1

596

P09327
DTMYVGRKLGLLFFP

YIF1B

116

Q5BJH7
GYPLRAFKLASLAMS

ZSWIM5

1011

Q9P217
RFKSYLLSMGIANPV

VPS36

216

Q86VN1
FPGQILRSSFGKQYM

TRMT61B

196

Q9BVS5
GLKTGMYYLRTRPAA

RRM1

731

P23921
TETNVYFKLMRLPGG

PPAN

91

Q9NQ55
YFKLMRLPGGPTLTF

PPAN

96

Q9NQ55
SRGLGMAYFPAISLS

RNF123

226

Q5XPI4
GLLYRMLPTNTFAFK

TIGD4

186

Q8IY51
AKMLYIQALPGPFLS

WDFY4

1191

Q6ZS81
LYGSIPKAAVRFGMF

SLC25A1

91

P53007
TGKFAPYLSQMSNLR

PRAMEF10

221

O60809
FLPGMAIGYSSSKLT

SRM

136

P19623
GDYRIPKAMLTFLNG

PKHD1L1

3716

Q86WI1
LKPLGTYILYGSSNM

VAT1L

266

Q9HCJ6
SPILARYGMDKQTGR

VCPIP1

131

Q96JH7
ALQMAFKLGLSYTPL

PRKDC

751

P78527
EGTPYAGGLFRMKLL

UBE2S

51

Q16763
GGKDSASPRYIFTML

TOP2A

796

P11388
LSYGLLMGAKFSDAP

WNT11

161

O96014
SYAVGLAALRGPMQL

TMEM160

116

Q9NX00
FPGDRLQGLSSLMYA

TTC39C

246

Q8N584
LKYNSPGMTRSNVLF

TTLL7

866

Q6ZT98
KLGIPFMYTLRFSPA

UGT2A2

171

P0DTE5
IRGPAYMFNEKGTSL

TRPC7

26

Q9HCX4
FGGRKNAVISLPSMY

ZAN

2446

Q9Y493
FYTEILNGLKPAGMA

MORN5

91

Q5VZ52
YDMSLLKNRFLRPGD

KLK3

101

P07288
YGNPLSMAGLKELLR

LRRC14

401

Q15048
RFMKYLLNFIGQGPA

MYO7B

1146

Q6PIF6